Search This Blog

Monday, April 8, 2019

Medtronic: New Value-Based Agreement with MN Blues on Diabetes Tech

Agreement Focuses on the Guardian Connect Smart CGM System, Improved Member Engagement and Measuring Time in Range
Blue Cross and Blue Shield of Minnesota and Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, announce a new outcomes-based agreement that provides members of the Blue Cross and Blue Shield of Minnesota plan who live with diabetes improved access to the Guardian(TM) Connect smart Continuous Glucose Monitoring (CGM) system. The system will also now be made available through a member’s pharmacy benefit, improving speed of delivery and may lower costs for members who use the device. Using the amount of time spent in a healthy glucose range as a key metric, value-based payments will be tied to the percentage of Time in Range achieved using the Guardian Connect system.
In addition, Medtronic is providing Blue Cross and Blue Shield of Minnesota members on the Guardian Connect system or the MiniMed(TM) 670G insulin pump system the opportunity to participate in the Medtronic Inner Circle SM program. Medtronic Inner Circle is a patient engagement program that uses gamification – the application of game design elements – to help people living with diabetes to achieve better health outcomes through education, motivation and inspiration. Members who choose to participate in the program have the opportunity to earn points by completing certain activities or achieving monthly Time in Range goals.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.